| P50 | author | Maurizio Sanguinetti | Q38325512 |
| | Brunella Posteraro | Q41881644 |
| P2860 | cites work | Discrimination of Aspergillus isolates at the species and strain level by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry fingerprinting | Q23915627 |
| | Antifungal susceptibility testing: current role from the clinical laboratory perspective | Q26862478 |
| | Mould routine identification in the clinical laboratory by matrix-assisted laser desorption ionization time-of-flight mass spectrometry | Q28478418 |
| | Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry | Q29616600 |
| | Characterization of Aspergillus spores by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry | Q30976491 |
| | Molecular studies reveal frequent misidentification of Aspergillus fumigatus by morphotyping | Q31065559 |
| | Pandora's mycological box: molecular sequences vs. morphology in understanding fungal relationships and biodiversity | Q33267893 |
| | What is a species in Aspergillus? | Q33414143 |
| | Filamentous fungal characterizations by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. | Q33491237 |
| | MALDI-TOF MS-based drug susceptibility testing of pathogens: the example of Candida albicans and fluconazole | Q33502781 |
| | Changes in the proteome of Candida albicans in response to azole, polyene, and echinocandin antifungal agents | Q33530441 |
| | Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for fast and accurate identification of clinically relevant Aspergillus species. | Q33645843 |
| | Proteomics for routine identification of microorganisms | Q33949796 |
| | Species identification of Aspergillus, Fusarium and Mucorales with direct surface analysis by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. | Q34007574 |
| | Two new aflatoxin producing species, and an overview of Aspergillus section Flavi | Q34011033 |
| | MALDI-TOF MS Andromas strategy for the routine identification of bacteria, mycobacteria, yeasts, Aspergillus spp. and positive blood cultures | Q34063840 |
| | The essence on mass spectrometry based microbial diagnostics | Q34191944 |
| | Routine identification of medical fungi by the new Vitek MS matrix-assisted laser desorption ionization-time of flight system with a new time-effective strategy | Q34229233 |
| | Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for caspofungin susceptibility testing of Candida and Aspergillus species | Q34246802 |
| | Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based method for discrimination between molecular types of Cryptococcus neoformans and Cryptococcus gattii | Q34264267 |
| | MALDI-TOF MS enables the rapid identification of the major molecular types within the Cryptococcus neoformans/C. gattii species complex | Q34292528 |
| | Development of a clinically comprehensive database and a simple procedure for identification of molds from solid media by matrix-assisted laser desorption ionization-time of flight mass spectrometry | Q34523418 |
| | MALDI-TOF-MS-based species identification and typing approaches in medical mycology. | Q34529370 |
| | Matrix-assisted laser desorption ionization-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology | Q34653849 |
| | Assessment of various parameters to improve MALDI-TOF MS reference spectra libraries constructed for the routine identification of filamentous fungi | Q34658975 |
| | MALDI-TOF mass spectrometry in the clinical mycology laboratory: identification of fungi and beyond | Q34662276 |
| | Matrix-assisted laser desorption ionization-time of flight mass spectrometry in clinical microbiology | Q34675879 |
| | Rapid antifungal susceptibility testing by matrix-assisted laser desorption ionization-time of flight mass spectrometry analysis | Q34793588 |
| | Update on the laboratory diagnosis of invasive fungal infections | Q35010667 |
| | MALDI-TOF MS: an upcoming tool for rapid detection of antibiotic resistance in microorganisms | Q35016718 |
| | Identification and typing of the Candida parapsilosis complex: MALDI-TOF MS vs. AFLP. | Q35104155 |
| | The evolutionary imprint of domestication on genome variation and function of the filamentous fungus Aspergillus oryzae. | Q36157418 |
| | The current status of species recognition and identification in Aspergillus | Q36509356 |
| | Sequence-based identification of Aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here? | Q37156876 |
| | Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network | Q37374801 |
| | Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance | Q37389864 |
| | Azole-resistance in Aspergillus: proposed nomenclature and breakpoints | Q37625111 |
| | Current status and future perspectives on molecular and serological methods in diagnostic mycology | Q37628677 |
| | What does genetic diversity of Aspergillus flavus tell us about Aspergillus oryzae? | Q37694041 |
| | Misidentification of Aspergillus nomius and Aspergillus tamarii as Aspergillus flavus: characterization by internal transcribed spacer, β-Tubulin, and calmodulin gene sequencing, metabolic fingerprinting, and matrix-assisted laser desorption ionizat | Q37713410 |
| | In vitro susceptibility testing in Aspergillus species: an update | Q37742178 |
| | Aspergillus species intrinsically resistant to antifungal agents. | Q37775969 |
| | Emerging moulds: epidemiological trends and antifungal resistance | Q37889387 |
| | Invasive mycoses: diagnostic challenges | Q37971083 |
| | Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment | Q37971085 |
| | The evolving role of antifungal susceptibility testing | Q38095809 |
| | Azole resistance in Aspergillus fumigatus: a growing public health concern. | Q38152679 |
| | Reply to "risks of 'blind' automated identification systems in medical microbiology". | Q42745309 |
| | Risks of "blind" automated identification systems in medical microbiology | Q42745311 |
| | Aspergillus species identification in the clinical setting. | Q43087816 |
| | Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles | Q44157648 |
| | MALDI-TOF mass spectrometry and microsatellite markers to evaluate Candida parapsilosis transmission in neonatal intensive care units. | Q50941306 |
| P433 | issue | 5-6 | |
| P921 | main subject | matrix-assisted laser desorption/ionization | Q736400 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 417-426 | |
| P577 | publication date | 2014-07-08 | |
| P1433 | published in | Mycopathologia | Q15763210 |
| P1476 | title | MALDI-TOF mass spectrometry: any use for Aspergilli? | |
| P478 | volume | 178 | |